Joshua Hare
Fortune : 225 018 $ au 31/08/2025
Fortune : 225 018 $ au 31/08/2025
Joshua M.
Hare is the founder of Biscayne Pharmaceuticals, Inc., founded in 2012.
Dr. Hare is the founder of Longeveron, Inc., founded in 2014, and holds the title of Executive Chairman & Chief Science Officer since 2025.
Dr. Hare is also the founder of Vestion, Inc.,Heart Genomics LLC..
Dr. Hare currently serves as Director of the Interdisciplinary Stem Cell Institute at The University of Miami Leonard M.
Miller School of Medicine.
Dr. Hare is a member of the Association of American Physicians and the American Society for Clinical Investigation.
Dr. Hare completed undergraduate education at the University of Pennsylvania and earned a doctorate from The Johns Hopkins University School of Medicine.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LONGEVERON INC. CLASS A 0,97 % | 30/04/2026 | 291 465 ( 0,97 % ) | 225 011 $ | 31/05/2026 |
LONGEVERON INC. 48,94 % | 30/04/2026 | 726 291 ( 48,94 % ) | 7 $ | 31/08/2025 |
| Sociétés | Poste | Début |
|---|---|---|
| LONGEVERON INC. | Fondateur | 09/10/2014 |
The University of Miami Leonard M. Miller School of Medicine
The University of Miami Leonard M. Miller School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Association of American Physicians
Association of American Physicians Miscellaneous Commercial ServicesCommercial Services Operates American association of physicians | Corporate Officer/Principal | - |
American Society for Clinical Investigation
American Society for Clinical Investigation BiotechnologyHealth Technology Provides clinical investigation services | Corporate Officer/Principal | - |
| Sociétés | Poste | Fin |
|---|---|---|
Heart Genomics LLC
Heart Genomics LLC Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company, which focuses on development and commercialization of non-invasive genomic-based clinical diagnostic tests for patients with heart disease and failure | Fondateur | - |
Biscayne Pharmaceuticals, Inc.
Biscayne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and pharmaceutical products | Fondateur | - |
Vestion, Inc.
Vestion, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Fondateur | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 9 |
|---|---|
Biscayne Pharmaceuticals, Inc.
Biscayne Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs and pharmaceutical products | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Association of American Physicians
Association of American Physicians Miscellaneous Commercial ServicesCommercial Services Operates American association of physicians | Commercial Services |
American Society for Clinical Investigation
American Society for Clinical Investigation BiotechnologyHealth Technology Provides clinical investigation services | Health Technology |
The Johns Hopkins University School of Medicine
The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Miami Leonard M. Miller School of Medicine
The University of Miami Leonard M. Miller School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Longeveron, Inc.
Longeveron, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops cellular therapies for aging-related and life-threatening conditions | Health Technology |
Vestion, Inc.
Vestion, Inc. Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Heart Genomics LLC
Heart Genomics LLC Miscellaneous Commercial ServicesCommercial Services Operates as biotechnology company, which focuses on development and commercialization of non-invasive genomic-based clinical diagnostic tests for patients with heart disease and failure | Commercial Services |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national